Eligibility criteria in phase 3 randomized controlled trials in metastatic non–small cell lung cancer
The eligibility criteria in phase 3 RCTs in metastatic NSCLC continue to be strict. In some trials, judicious modifications of these criteria should be considered to improve the enrollment of clinically relevant populations of patients, especially older adults, individuals with an ECOG score of 2, and those with selected comorbidities.
Authors
- Danuta Kłosowska
- Jan Borysowski (ORCID: https://orcid.org/0000-0001-5256-1959)
- Magdalena Knetki‐Wróblewska (ORCID: https://orcid.org/0000-0002-7603-099X)
- M. Krzakowski
- Marek Harhala
Institutions
- Medical University of Warsaw (PL)
- National Institute of Oncology (HU)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Adam Mickiewicz University in Poznań (PL)
Publication Details
- Journal
- Cancer
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1002/cncr.70361
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00